The Ophthalmic Drugs Market is expected to be around US$ 61.50 Billion by 2028 at a CAGR of 6.78% in the given forecast period.
The ophthalmic drugs are the formulations that are planned for the treatment of eye diseases such as diabetic macular edema, cytomegalovirus retinitis, cataract, glaucoma, colour blindness, and age-related macular degeneration. Growth in geriatric population; growth in prevalence of eye disease such as cataract, glaucoma, and macular degeneration; surge in demand of ophthalmic drug, and growth in investment in R&D activities by many healthcare companies are the key factors that drive the development of the global ophthalmic drugs market. Moreover, surge in demand for ophthalmic drugs, growth in alertness about healthcare to prevent the risk of eye diseases, and initiatives taken by government for development & manufacturing of different mixture of ophthalmic drugs propel the development of the market. Nevertheless, prolonged time period for manufacturing and formulating the ophthalmic drug as well as side effects associated with the ophthalmic drugs are expected to restrict the market development during the forecast period. Growing alertness about eye-related diseases and increasing advancements in technologies are some of the major factors expected to accelerate market development.
The global Ophthalmic Drugs market is segregated on the basis of Drug Class as Anti-glaucoma Drug, Dry eye Drug, Ophthalmic Anti-allergy/Inflammatory, Retinal Drug, Anti-infective Drugs, and Other Drugs. Based on Product Type the global OPHTHALMIC DRUGS market is segmented in OTC Drug, Prescription Drug, and Residential.
The global Ophthalmic Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The OPHTHALMIC DRUGS market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Alcon, Johnson & Johnson Services, Inc., Bausch Health, Allergan, Pfizer, Inc., Bayer AG, Santen Pharmaceutical Co. Ltd., Genentech, Inc., Novartis AG, Regeneron, and others are among the major players in the global OPHTHALMIC DRUGS market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Ophthalmic Drugs Market has been segmented as below:
Ophthalmic Drugs Market, By Drug Class
Ophthalmic Drugs Market, By Product Type
Ophthalmic Drugs Market, By Region
Ophthalmic Drugs Market, By Company
The report covers:
Report Scope:
The global Ophthalmic Drugs market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Ophthalmic Drugs market share. Major industry players with significant revenue share include Alcon, Johnson & Johnson Services, Inc., Bausch Health, Allergan, Pfizer, Inc., Bayer AG, Santen Pharmaceutical Co. Ltd., Genentech, Inc., Novartis AG, Regeneron, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Nonalcoholic Steatohepatitis market
Protein Purification & Isolation Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Ophthalmic Drugs Market, By Drug Class
5.1. Key Points
5.2. Anti-glaucoma Drug
5.3. Dry eye Drug
5.4. Ophthalmic Anti-allergy/Inflammatory
5.5. Retinal Drug
5.6. Anti-infective Drugs
5.7. Other Drugs
6. Ophthalmic Drugs Market, By Product Type
6.1. Key Points
6.2. OTC Drug
6.3. Prescription Drug
6.4. Residential
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profiles
8.1 Alcon
8.1.1 Company Overview
8.1.2 Product/Service Landscape
8.1.3 Financial Overview
8.1.4 Recent Developments
8.2 Johnson & Johnson Services, Inc.
8.2.1 Company Overview
8.2.2 Product/Service Landscape
8.2.3 Financial Overview
8.2.4 Recent Developments
8.3 Bausch Health
8.3.1 Company Overview
8.3.2 Product/Service Landscape
8.3.3 Financial Overview
8.3.4 Recent Developments
8.4 Allergan
8.4.1 Company Overview
8.4.2 Product/Service Landscape
8.4.3 Financial Overview
8.4.4 Recent Developments
8.5 Pfizer, Inc.
8.5.1 Company Overview
8.5.2 Product/Service Landscape
8.5.3 Financial Overview
8.5.4 Recent Developments
8.6 Bayer AG
8.6.1 Company Overview
8.6.2 Product/Service Landscape
8.6.3 Financial Overview
8.6.4 Recent Developments
8.7 Santen Pharmaceutical Co. Ltd.
8.7.1 Company Overview
8.7.2 Product/Service Landscape
8.7.3 Financial Overview
8.7.4 Recent Developments
8.8 Genentech, Inc.
8.8.1 Company Overview
8.8.2 Product/Service Landscape
8.8.3 Financial Overview
8.8.4 Recent Developments
8.9 Novartis AG
8.9.1 Company Overview
8.9.2 Product/Service Landscape
8.9.3 Financial Overview
8.9.4 Recent Developments
8.10 Regeneron
8.10.1 Company Overview
8.10.2 Product/Service Landscape
8.10.3 Financial Overview
8.10.4 Recent Developments
The Ophthalmic Drugs Market has been segmented as below:
Ophthalmic Drugs Market, By Drug Class
Ophthalmic Drugs Market, By Product Type
Ophthalmic Drugs Market, By Region
Ophthalmic Drugs Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
